Citizens Examines Access, Cost Issues For Lipitor To Zocor HomeUSA Today examined on Monday U.S. Citizens U.S. Citizens began to realize that the anti – cholesterol drug Lipitor is manufactured by Pfizer, is ‘difficult and expensive get ‘as an employer recommend the use of generic medications prescription drugs prescription drugs. In June, generic versions of Zocor, a rival drug made by Merck, the market, and a number of employers, including General Motors have begun to encourage employees to switch from Lipitor Zocor. According to Consumer Reports Best Buy Drugs, about 60 percent of U.S. Citizens who take brand – name anti – cholesterol drugs could safely switch to generic Zocor, a move that could save $ 7 billion to $ 11 billion a year for costs prescription drugs.
‘courtesy of you, the entire Kaiser Daily Health Policy view Report, search the archives, or sign up for e-mail delivery at Kaiser Daily Health Policy Report published reprint of imperial network. A free service of The Henry J. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.NextStepAfter the phase I clinical trial being officially concluded, Sinovac is starting the application process to SFDA start of the Phase II study approved. The company is. Their summary report of the Phase I clinical study, planning and protocol for Phase II clinical trial and other relevant documents.
In the clinical trial 120 volunteers have been into 4 different groups of 30 persons each, 24 of which are out of of pandemic influenza a vaccine and the remaining 6 vaccinated with a placebo have been divided. Safety of vaccines was documented by routing blood test, Biochemistry blood tests, urine testing and routing systemic observing of localized events. Shows the preliminary results, that Sinovac vaccine is safe for human consumption, no serious adverse events occurred in all volunteer.